37 studies found for:    "myasthenia gravis"
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: eculizumab;   Drug: Placebo
22 Completed A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Condition: Myasthenia Gravis Generalised
Interventions: Drug: mycophenolate mofetil [CellCept];   Drug: Placebo
23 Completed A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: mycophenolate mofetil (CellCept);   Drug: placebo
24 Active, not recruiting The Role of the Thymus in Myasthenia Gravis
Conditions: Myasthenia Gravis;   Thymoma
Intervention:
25 Unknown  Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: immune globulin
26 Recruiting The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
Condition: Myasthenia Gravis
Interventions: Drug: Azathioprine;   Drug: Leflunomide
27 Recruiting Therapeutic Plasma Exchange in MG
Condition: Myasthenia Gravis
Interventions: Other: Skin biopsy;   Other: Single Fiber Electromyography
28 Completed An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Condition: Myasthenia Gravis
Intervention: Drug: tacrolimus
29 Not yet recruiting Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Conditions: Myasthenia Gravis;   Systemic Lupus Erythematosus;   Rheumatoid Arthritis
Intervention: Drug: Bortezomib
30 Active, not recruiting Serum Auto-Antibodies
Conditions: Multiple Sclerosis;   Myasthenia Gravis;   Transverse Myelitis
Intervention: Other: Blood Draw
31 Recruiting Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Myasthenia Gravis;   Myopathies;   Stroke;   Parkinson's Disease
Intervention:
32 Terminated Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo
33 Completed Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
Condition: Myasthenia Gravid
Interventions: Biological: IVIG;   Procedure: PLEX
34 Not yet recruiting Perception and Multisensory Integration in Neurological Patients Using fMRI
Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy;   Myasthenia Gravis;   Stroke;   Anosognosia;   Asomatognosia
Intervention: Device: Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla
35 Enrolling by invitation Study of an Intervention to Improve Problem List Accuracy and Use
Conditions: Attention Deficit Disorder With Hyperactivity;   Asthma;   COPD;   Breast Cancer;   Coronary Artery Disease;   Congestive Heart Failure;   Diabetes;   Glaucoma;   Hemophilia;   Hypertension;   Hyperthyroidism;   Hypothyroidism;   Myasthenia Gravis;   Osteoporosis;   Osteopenia;   Renal Failure;   Renal Insufficiency;   Sickle Cell Disease;   Stroke
Intervention: Other: MAPLE
36 Recruiting The Evaluation of Belimumab in Myasthenia Gravis (MG)
Condition: Myasthaenia Gravis
Interventions: Biological: Belimumab;   Other: Placebo
37 Available Treatment Use of 3,4-Diaminopyridine
Conditions: Lambert Eaton Myasthenic Syndrome (LEMS);   Myasthenic Syndromes, Congenital
Intervention: Drug: 3,4-diaminopyridine

Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page
Indicates status has not been verified in more than two years